Allergan (AGN) Tops Q4 EPS by 34c
Tweet
Share
E-mailGet Alerts AGN Hot Sheet
Price: $193.02 --0%
Financial Fact:
Research and development: 288.5M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Research and development: 288.5M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Allergan (NYSE: AGN) reported Q4 EPS of $2.17, $0.34 better than the analyst estimate of $1.83. Revenue for the quarter came in at $1.91 billion versus the consensus estimate of $1.9 billion.
For earnings history and earnings-related data on Allergan (AGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
- 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
